Clincosm LogoSign in Get a demo

Alzheimer Disease

Showing NaN - NaN of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))

Completed
Has Results
  • Alzheimer Disease
  • Transcranial Alternating Current Stimulation (tACS)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 2, 2022

Alzheimer, Mild Cognitive Impairment Trial in Indianapolis, Boston, Jamaica Plain (Pramlintide challenge test)

Recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • Pramlintide challenge test
  • Indianapolis, Indiana
  • +2 more
Jan 27, 2022

Alzheimer Trial in United States (AMX0035, Placebo)

Completed
  • Alzheimer Disease
  • Jacksonville, Florida
  • +10 more
Nov 10, 2021

Alzheimer Dementia, Alzheimer, Dementia of Alzheimer Type Trial in Boston (Levetiracetam, Placebo oral capsule)

Recruiting
  • Alzheimer Dementia
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 3, 2021

Memory Disorders, Alzheimer, Mild Cognitive Impairment Trial in Boston (Technology based social interactions, No research

Completed
  • Memory Disorders
  • +2 more
  • Technology based social interactions
  • No research related technology based social interactions
  • Boston, Massachusetts
    Boston University Alzheimer Disease Center
Aug 27, 2021

Olfactory Deficits in Neurologic Disease

Completed
  • Alzheimer Disease
  • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 18, 2021

    Dementia, Dementia, Vascular, Dementia With Lewy Bodies Trial in United States (ADRD-PC Program)

    Enrolling by invitation
    • Dementia
    • +7 more
    • ADRD-PC Program
    • Denver, Colorado
    • +3 more
    Jul 29, 2021

    Stroke, Parkinson Disease, Multiple Sclerosis Trial in Finland, United States (Dysphagia Detection System)

    Terminated
    Has Results
    • Stroke
    • +5 more
    • Dysphagia Detection System
    • Downey, California
    • +12 more
    Apr 29, 2021

    Alzheimer, Amyloid Beta-Peptides, Risk Assessment Trial in United States (Alzheimer's Disease Risk Disclosure, Amyloid Brain

    Active, not recruiting
    • Alzheimer Disease
    • +5 more
    • Alzheimer's Disease Risk Disclosure
    • Amyloid Brain Imaging and Alzheimer's Disease Risk Disclosure
    • Boston, Massachusetts
    • +3 more
    Apr 30, 2021

    Brain Injuries, Traumatic, Demyelinating Disorder, Alzheimer Trial in Boston (F18-3F4AP)

    Recruiting
    • Brain Injuries, Traumatic
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Feb 23, 2021

    Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

    Completed
    Has Results
    • Alzheimer Disease
    • Phoenix, Arizona
    • +61 more
    Oct 17, 2019

    Alzheimer Trial in United States (Pleiotropic info, in-person disclosure, AD-only info, in-person disclosure, Pleiotropic info,

    Completed
    Has Results
    • Alzheimer Disease
    • Pleiotropic info, in-person disclosure
    • +3 more
    • Washington, District of Columbia
    • +3 more
    Sep 25, 2018

    Various Anesthetic Agents on Cognitive Function in Alzheimer's

    Withdrawn
    • Alzheimer Disease
      • Boston, Massachusetts
        Massachusetts General Hospital
      Aug 14, 2018

      Alzheimer, Mild Cognitive Impairment, Neurodegenerative Diseases Trial in United States (Florbetapir F 18)

      Completed
      Has Results
      • Alzheimer Disease
      • +2 more
      • Florbetapir F 18
      • Phoenix, Arizona
      • +25 more
      Jun 22, 2018

      Dementia, Alzheimer, Dementia, Vascular Trial in Boston (Zolpidem CR, Placebo)

      Completed
      Has Results
      • Dementia
      • +4 more
      • Zolpidem CR
      • Placebo
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 12, 2017

      Alzheimer Trial in United States (Naproxen Sodium (Aleve), Celecoxib (Celebrex))

      Completed
      • Alzheimer Disease
      • Naproxen Sodium (Aleve)
      • Celecoxib (Celebrex)
      • Sun City, Arizona
      • +5 more
      Oct 18, 2016

      Alzheimer Trial in Worldwide (bapineuzumab, )

      Terminated
      Has Results
      • Alzheimer Disease
      • Birmingham, Alabama
      • +286 more
      May 3, 2016

      Dementia, Alzheimer Trial in United States (Partners in Dementia Care)

      Completed
      Has Results
      • Dementia
      • Alzheimer Disease
      • Partners in Dementia Care
      • Boston, Massachusetts
      • +5 more
      May 10, 2016

      Alzheimer Trial in United States (ACC-001+ QS21 (3mcg), ACC-001 (10 mcg) + QS-21, ACC-001+QS-21 (30mcg))

      Terminated
      Has Results
      • Alzheimer Disease
      • ACC-001+ QS21 (3mcg)
      • +2 more
      • Phoenix, Arizona
      • +27 more
      Mar 2, 2016

      Alzheimer Trial in United States ([18F]NAV4694)

      Unknown status
      • Alzheimer Disease
      • New Haven, Connecticut
      • +6 more
      Mar 29, 2016

      Alzheimer Trial in Worldwide (bapineuzumab, )

      Terminated
      Has Results
      • Alzheimer Disease
      • Birmingham, Alabama
      • +347 more
      Dec 4, 2015

      Alzheimer Trial in United States (ACC-001 + QS-21, QS-21, Diluent: Phosphate Buffered Saline)

      Completed
      Has Results
      • Alzheimer Disease
      • ACC-001 + QS-21
      • +3 more
      • Phoenix, Arizona
      • +26 more
      Nov 30, 2015

      Alzheimer's Disease Anti-Inflammatory Prevention Trial

      Unknown status
      • Alzheimer Disease
      • Dementia
        • Sun City, Arizona
        • +5 more
        Jan 5, 2012

        Alzheimer Trial in United States (Leuprolide acetate)

        Completed
        • Alzheimer Disease
        • Leuprolide acetate
        • Fresno, California
        • +12 more
        Dec 10, 2009

        Alzheimer Trial in United States (Estrogen)

        Completed
        • Alzheimer Disease
        • Birmingham, Alabama
        • +24 more
        Dec 10, 2009